Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead to a similar oncological outcome compared to non-aged patients – Results of the RESPECT-Study

Autor: Schmid, Daniel, D'Haese, Jan G., Böck, Stephan, Kruger, Stephan, Haas, Michael, Röder, Falk, Chiaro, Marco del, Löhr, Matthias, Tamburrino, Domenico, Masini, Gaia, Maisonneuve, Patrick, Malleo, Giuseppe, Salvia, Roberto, Charnley, Richard, Weniger, Maximilian, Moir, John, Damm, Marko, Maggino, Laura, Kordes, Maximilian, Rosendahl, Jonas, Ceyhan, Güralp O., Schorn, Stephan
Zdroj: In Surgical Oncology December 2020 35:285-297
Databáze: ScienceDirect
Externí odkaz: